Format

Send to

Choose Destination
Curr Opin Investig Drugs. 2006 Aug;7(8):766-72.

Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.

Author information

1
Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK. f.odds@abdn.ac.uk

Abstract

Basilea Pharmaceutica is developing BAL-8557, a water-soluble prodrug of the triazole BAL-4815, for the potential treatment of fungal infections. By August 2005, a phase II study in oral candidiasis was underway. In September 2005, phase III trials were planned for invasive Candida and mold infections, including aspergillus and zygomycetes.

PMID:
16955689
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center